Sionna Therapeutics Inc (SION) Annual Balance Sheets

Annual · GAAP · USD millions
Access SION quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Sionna Therapeutics Inc.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Assets
Cash & cash equivalent58.45
Cash & Short-term Investments58.00
Other Current Assets177.43
Prepaid Expense And Other Assets Current5.54
Total Current Assets241.42
Equipment/Property/Plant Net2.23
Debt Securities Available For Sale Excluding Accrued Interest Current177.43
Debt Securities Available For Sale Excluding Accrued Interest Noncurrent74.42
Restricted Cash Noncurrent0.96
Operating Lease Right Of Use Asset6.93
Total Assets325.95
Liabilities
Accounts Payable AC0.77
Accrued Liabilities, Current AC9.67
Other Liabilities, Current1.28
Total Current Liabilities11.71
Total Long-term Debt0.00
Other liabilities, Noncurrent7.41
OperatingLeaseLiabilityNoncurrent7.41
Operating Lease Liability Current1.27
Total Liabilities19.12
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock562.60
Retained Earnings / Accumulated Deficit-256.35
Other Equity0.54
Common Stockholder's Equity306.83
Total Stockholder's Equity306.83
Liabilities & Stockholder's Equity325.95
4 historic quarters locked

Sign in to unlock the full Sionna Therapeutics Inc balance sheet history.

About Sionna Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-012996

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.